Todays Report: Today: UnitedHealth Group Inc. (UNH) Issues FY17 Earnings Guidance

Today: UnitedHealth Group Inc. (UNH) Issues FY17 Earnings Guidance

UnitedHealth Group Inc. (NYSE:UNH) issued an update on its FY17 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $9.30-9.60 for the period, compared to the Thomson Reuters consensus estimate of $9.11. The company issued revenue guidance of $197-199 billion, compared to the consensus revenue estimate of $196.76 billion.UnitedHealth Group also updated its FY16 guidance to ~$8.00 EPS.

UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% during midday trading on Monday, reaching $152.11. The company had a trading volume of 5,022,344 shares. The firm has a 50-day moving average of $143.37 and a 200-day moving average of $139.61. The stock has a market cap of $144.61 billion, a P/E ratio of 25.31 and a beta of 0.63. UnitedHealth Group Inc. has a 12 month low of $107.51 and a 12 month high of $154.50.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.09. The firm had revenue of $46.30 billion for the quarter, compared to the consensus estimate of $46.09 billion. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The business’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.77 earnings per share. On average, equities analysts expect that UnitedHealth Group Inc. will post $8.01 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be given a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.93%.

A number of equities research analysts have recently issued reports on the company. Credit Suisse Group AG restated an outperform rating and set a $160.00 price objective (up previously from $155.00) on shares of UnitedHealth Group in a report on Friday, October 21st. Mizuho boosted their price target on UnitedHealth Group from $160.00 to $169.00 and gave the company a buy rating in a research note on Wednesday, October 19th. Cowen and Company set a $150.00 price target on UnitedHealth Group and gave the company a buy rating in a research note on Tuesday, September 6th. Leerink Swann set a $175.00 price target on UnitedHealth Group and gave the company a buy rating in a research note on Wednesday, October 19th. Finally, Evercore ISI assumed coverage on UnitedHealth Group in a research note on Thursday, September 22nd. They issued a buy rating and a $155.00 price target for the company. Two analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company. The stock presently has an average rating of Buy and a consensus target price of $158.03.

In other UnitedHealth Group news, EVP D Ellen Wilson sold 14,365 shares of the company’s stock in a transaction on Friday, October 21st. The shares were sold at an average price of $144.18, for a total transaction of $2,071,145.70. Following the sale, the executive vice president now owns 66,635 shares of the company’s stock, valued at $9,607,434.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,460 shares of the company’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $150.55, for a total transaction of $822,003.00. Following the sale, the director now directly owns 60,052 shares in the company, valued at approximately $9,040,828.60. The disclosure for this sale can be found here. Company insiders own 1.65% of the company’s stock.

A number of hedge funds have recently modified their holdings of UNH. Capital Research Global Investors boosted its stake in shares of UnitedHealth Group by 0.5% in the second quarter. Capital Research Global Investors now owns 29,118,588 shares of the healthcare conglomerate’s stock worth $4,111,545,000 after buying an additional 147,410 shares during the period. Credit Suisse AG boosted its stake in shares of UnitedHealth Group by 1.8% in the second quarter. Credit Suisse AG now owns 10,523,146 shares of the healthcare conglomerate’s stock worth $1,485,869,000 after buying an additional 184,472 shares during the period. Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of UnitedHealth Group by 6.8% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 3,739,600 shares of the healthcare conglomerate’s stock worth $528,032,000 after buying an additional 239,700 shares during the period. Parametric Portfolio Associates LLC boosted its stake in shares of UnitedHealth Group by 7.2% in the second quarter. Parametric Portfolio Associates LLC now owns 2,722,079 shares of the healthcare conglomerate’s stock worth $384,358,000 after buying an additional 183,978 shares during the period. Finally, American Century Companies Inc. boosted its stake in shares of UnitedHealth Group by 3.7% in the second quarter. American Century Companies Inc. now owns 2,624,148 shares of the healthcare conglomerate’s stock worth $370,530,000 after buying an additional 93,633 shares during the period. 84.92% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

Related posts

Leave a Comment